Renal denervation for uncontrolled hypertension
- PMID: 37931951
- PMCID: PMC10627573
- DOI: 10.1503/cmaj.230745
Renal denervation for uncontrolled hypertension
Conflict of interest statement
Competing interests: Sheldon Tobe reports payment from Medtronic Canada. Andrew Dueck reports payment for expert testimony, patents related to magnetic resonance imaging sequences for the evaluation of peripheral plaque. He holds the Maggisano chair in vascular surgery. Mina Madan reports participation on an advisory board for Medtronic Canada. No other competing interests were declared.
Figures
References
-
- Leung AA, Williams JVA, McAlister FA, et al. . Worsening hypertension awareness, treatment, and control rates in Canadian women between 2007 and 2017. Can J Cardiol 2020;36:732–9. - PubMed
-
- Kandzari DE, Townsend RR, Bakris G, et al. . Renal denervation in hypertension patients: proceedings from an expert consensus roundtable cosponsored by SCAI and NKF. Catheter Cardiovasc Interv 2021;98:416–26. - PubMed
-
- Blood Pressure Lowering Treatment Trialists’ Collaboration. Blood pressure-lowering treatment based on cardiovascular risk: a meta-analysis of individual patient data. Lancet 2014;384:591–8. - PubMed
-
- Mahfoud F, Schlaich MP, Lobo MD. Device therapy of hypertension. Circ Res 2021;128:1080–99. - PubMed
-
- Barbato E, Azizi M, Schmieder RE, et al. . Renal denervation in the management of hypertension in adults. A clinical consensus statement of the ESC Council on Hypertension and the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J 2023;44:1313–30. doi:10.1093/eurheartj/ehad054. - DOI - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical